Vertec Scientific Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vertec Scientific Limited - overview
Established
1982
Location
Guildford, -, UK
Primary Industry
Consumer Products
About
Vertec Scientific Limited specializes in advanced medical imaging and radiotherapy solutions, enhancing diagnostic capabilities and treatment workflows for healthcare professionals. Vertec Scientific Limited focuses on providing innovative medical imaging solutions. Founded in 1982, it has established itself in the healthcare sector, although there are no noted pivots in business strategy or operations. The company operates from its headquarters in the United Kingdom and has not been reported as a subsidiary of any parent company.
Information about the founder is not available. Vertec Scientific Limited specializes in advanced medical imaging and radiotherapy solutions, focusing on enhancing diagnostic capabilities and treatment workflows in healthcare settings. The company's core offerings include the Ortho350 system, a groundbreaking digital tomosynthesis solution tailored for extremity imaging, which utilizes high-resolution 3D imaging derived from quick, low-dose X-rays. Additionally, Vertec distributes the Art.
1 radiotherapy workflow tool, designed to streamline treatment planning processes for radiotherapy teams by consolidating essential information into a user-friendly platform. These products are aimed primarily at hospitals, clinics, and specialized radiology practices across the UK market, catering to healthcare professionals who require efficient and reliable imaging and treatment solutions. Vertec Scientific Limited's revenue generation is supported by its strategic partnerships and distribution agreements within the healthcare sector. The company engages in direct B2B transactions with healthcare facilities, offering its flagship products such as the Ortho350 and Art.
1 through exclusive partnerships, ensuring streamlined access to these innovative solutions. The revenue model is structured around product sales and ongoing support services that accompany the installation of imaging systems and workflow tools. Clients typically engage in purchasing contracts that may include maintenance and training services, fostering long-term relationships that enhance client satisfaction and operational efficiency within their healthcare practices.
Primary Industry
Consumer Products
Sub Industries
Consumer Products
Website
www.vertec.co.uk
Total Amount Raised
Subscriber access only
Vertec Scientific Limited - timeline of key events
Vertec Scientific Limited - financials
| Fiscal Year Ended | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 |
|---|---|---|---|---|---|---|
| Revenue (USD) | 6,085,000 | 6,219,000 | 5,430,000 | - | - | - |
| % Revenue Growth (YoY) | - | 2.2% | (12.7%) | - | - | - |
| EBITDA (USD) | 1,451,000 | 1,505,000 | 1,142,000 | - | - | - |
| Operating Income (USD) | 1,437,000 | 1,491,000 | 1,135,000 | - | - | - |
| Operating Margin | 23.6% | 24.0% | 20.9% | - | - | - |
| % EBITDA Margin | 23.8% | 24.2% | 21.0% | - | - | - |
| NET Income (USD) | 1,707,000 | 1,780,000 | 912,000 | - | - | - |
| % Net Margin | 28.1% | 28.6% | 16.8% | - | - | - |
Vertec Scientific Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.